Effect of Cherenkov light on cell survival in x-ray irradiation of LINAC based on Monte Carlo simulation and cell survival measurements.
| Autor: | Hirano Y; Graduate School of Medicine, Biomedical Imaging Sciences, Nagoya University, Japan., Terada Y; School of Health Sciences, Department of Radiological Technology, Nagoya University, Japan. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Biomedical physics & engineering express [Biomed Phys Eng Express] 2024 Dec 04; Vol. 11 (1). Date of Electronic Publication: 2024 Dec 04. |
| DOI: | 10.1088/2057-1976/ad96c1 |
| Abstrakt: | Cherenkov radiation is emitted during x-ray irradiation in a linear accelerator (LINAC). Cherenkov light contains many short wavelength components, including ultraviolet (UV) light, which is well-known for its bactericidal effects. A similar phenomenon is probable for human cancer cells. To assess the effect of Cherenkov light on cell death in x-ray irradiation, we employed simulations and UV cell survival data. We measured the survival rates of HeLa cells exposed to 254 nm (UVC) and 310 nm (UVB) light to determine the 50% lethal dose (LD50) required to kill 50% of the cells. For other wavelengths, we utilized literature values to establish the relationship between wavelength and LD50. Due to the broad range of the Cherenkov light spectrum, we need LD50 as a function of wavelength to estimate cell survival solely from Cherenkov light. A Monte Carlo simulation was used to calculate the fluence distribution of Cherenkov light in a 300 mm 3 phantom comprised of soft tissue, both with and without absorption of visible light. The latter scenario is considered to be most influenced by Cherenkov light. By combining the fluence distribution and the wavelength-LD50 relationship, we determined the distribution of the survival rate. Our findings indicate that, in the absence of absorption, a radiation dose of approximately 90 Gy or greater is necessary for Cherenkov light to have any effect. As a result, the impact of Cherenkov light on cell survival can be considered negligible for typical dose of 2 Gy. (© 2024 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|